Baidu
map

Eur Heart J:健康人群氧摄取峰值与冠状动脉心脏病的关系

2018-11-29 xing.T MedSci原创

由此可见,在低风险人群样本中,VO2峰值与CHD之间呈负相关。增加VO2峰值可能对减轻CHD的负担有很大的好处。

之前关于心肺健康(CRF)和血管疾病(CVD)之间关联的大多数研究都是基于对男性人群CRF的间接评估。近日,血管领域权威杂志Eur Heart J上发表了一篇研究文章,研究人员的目的是评估健康人群中通过金标准的心肺运动测试方法测量的VO2峰值与致命和非致命性冠心病(CHD)之间的关联。

研究人员将来自于大型人群健康研究(HUNT3研究)中4527名(51%女性)之前没有心血管或肺病、癌症、高血压或服用抗高血压药物的成年人VO2峰值数据,并与医院登记处和死因登记处进行联系。

女性和男性的平均VO2峰值分别为36.0 mL/kg/min和44.4 mL/kg/min,基线时的10年CVD风险为83.5%。平均随访时间为8.8年,147名参与者出现主要终点。多重调整的Cox回归显示,VO2峰值每增加一MET(代谢当量任务)主要终点风险降低15%[风险比(HR)为0.85,95%置信区间(CI)为0.77-0.93],在男性和女性中结果相似。与最低四分位数相比,VO2峰值最高四分位数事件风险降低48%(多重调整后的HR为0.52,95%CI为0.33-0.82)。氧气和二氧化碳的氧气脉冲和通气等效物也显示出对主要终点显著的预测价值。

由此可见,在低风险人群样本中,VO2峰值与CHD之间呈负相关。增加VO2峰值可能对减轻CHD的负担有很大的好处。

原始出处:


Jon Magne Letnes.et al.Peak oxygen uptake and incident coronary heart disease in a healthy population: the HUNT Fitness Study. Eur Heart J.2018. https://doi.org/10.1093/eurheartj/ehy708

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1911126, encodeId=096a1911126cd, content=<a href='/topic/show?id=8c0d2e73196' target=_blank style='color:#2F92EE;'>#健康人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27731, encryptionId=8c0d2e73196, topicName=健康人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55f6293, createdName=lishizhe, createdTime=Tue Aug 13 22:59:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357009, encodeId=3a33135e009c9, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Dec 01 03:59:00 CST 2018, time=2018-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563008, encodeId=a399156300868, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Dec 01 03:59:00 CST 2018, time=2018-12-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1911126, encodeId=096a1911126cd, content=<a href='/topic/show?id=8c0d2e73196' target=_blank style='color:#2F92EE;'>#健康人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27731, encryptionId=8c0d2e73196, topicName=健康人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55f6293, createdName=lishizhe, createdTime=Tue Aug 13 22:59:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357009, encodeId=3a33135e009c9, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Dec 01 03:59:00 CST 2018, time=2018-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563008, encodeId=a399156300868, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Dec 01 03:59:00 CST 2018, time=2018-12-01, status=1, ipAttribution=)]
    2018-12-01 zhaojie88
  3. [GetPortalCommentsPageByObjectIdResponse(id=1911126, encodeId=096a1911126cd, content=<a href='/topic/show?id=8c0d2e73196' target=_blank style='color:#2F92EE;'>#健康人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27731, encryptionId=8c0d2e73196, topicName=健康人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55f6293, createdName=lishizhe, createdTime=Tue Aug 13 22:59:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357009, encodeId=3a33135e009c9, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Dec 01 03:59:00 CST 2018, time=2018-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563008, encodeId=a399156300868, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Dec 01 03:59:00 CST 2018, time=2018-12-01, status=1, ipAttribution=)]
    2018-12-01 slcumt
Baidu
map
Baidu
map
Baidu
map